肠外水合没有癌症治疗的好处
![For patients with advanced cancer in hospices, providing parenteral saline (1 liter per day) does not improve symptoms associated with dehydration, quality of life, or overall survival compared with placebo, according to a study published online Nov. 19 in the <i>Journal of Clinical Oncology</i>. 肠外水合没有癌症治疗的好处](https://scx1.b-cdn.net/csz/news/800a/2012/parenteralhy.jpg)
(健康日) - 根据11月19日在线发布的一项研究,提供肠外癌症(每天1升)的患者,提供肠胃外盐水(每天1升),不会改善与安慰剂相比的脱水,生活质量或整体生存症状。这临床肿瘤学杂志。
检查肠外水合在先进的影响癌症护理in hospices, Eduardo Bruera, M.D., of the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a double-blind, randomized, placebo-controlled study involving 129 patients with advanced cancer from six hospices who received either parenteral administration of 1 liter of normal saline per day or placebo (normal saline 100 milliliter per day) over a four-hour period.
在第四天和七次肠胃外保湿之后,研究人员观察到两组在四个脱水症状的总和之间没有显着差异(疲劳,肌阵挛,镇静, 和幻觉)。同样,在用于评估整体症状,谵妄,肌阵挛,疲劳和脱水的五种尺度中没有观察到任何差异。两组之间的总生存率没有显着差异(中位数,21与15天; P = 0.83)。
“我们的研究支持当前的临终关怀实践,不经常管理水合,”作者写道。“需要进一步的研究来确定是否有任何亚组,例如恶毒的患者或患有更长的存活,将受益于肠外水合。”
进一步探索
版权所有©2012.健康天。版权所有。
用户评论